FDA inspection

UBI Pharma, Inc.: FDA inspection ending Jun 6, 2023

FDA inspection 1207579 · Voluntary Action Indicated (VAI) · Hsinchu County

Key facts

Inspection ID 1207579
Firm UBI Pharma, Inc.
FEI number 3004713402
Address 45 Guangfu N. Road
City Hsinchu County
Country Taiwan
Fiscal year 2023
Inspection end date Jun 6, 2023
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections